Patents by Inventor James Qun Xue

James Qun Xue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for predicting response of esophagus cancer to anti-ERBB3 antibody therapy, and kit
    Patent number: 11834716
    Abstract: Disclosed is a method for predicting whether esophageal cancer is sensitive or resistant to treatment with an ERBB3 inhibitor, e.g, an anti-ERBB3 antibody. Specifically, the method predicts by measurement of expression at the RNA level, or at the protein level, of at least one biomarker selected from SDC2, PTGES, NCF2, NOXA1, CARD6 and GNAZ in a tumor sample.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: December 5, 2023
    Assignee: Canbridge Life Sciences LTD
    Inventors: James Qun Xue, Jing Wang, Ya Gao, Huaizhong Hu
  • METHOD FOR PREDICTING RESPONSE OF ESOPHAGUS CANCER TO ANTI-ERBB3 ANTIBODY THERAPY, AND KIT
    Publication number: 20210025006
    Abstract: The invention discloses a method for predicting whether esophageal cancer is sensitive or resistant to treatment with an ERBB3 inhibitor, e.g, an anti-ERBB3 antibody. Specifically, the method predicts by measurement of expression at the RNA level, or at the protein level, of at least one biomarker selected from SDC2, PTGES, NCF2, NOXA1, CARD6 and GNAZ in a tumor sample.
    Type: Application
    Filed: June 12, 2018
    Publication date: January 28, 2021
    Inventors: James Qun Xue, Jing Wang, Ya Gao, Huaizhong Hu